Illustrative image – not actual.Maharashtra’s draft biotechnology policy, which is being finalised, is aimed at collaboration between biotechnology companies and the public health machinery.
The policy is aimed at creating a robust industry to develop better seeds suited to the agro-climatic conditions of the state, develop affordable and more effective drugs, develop cheap and effective technologies to purify water sources, enhance the value and utility of medicinal plants and traditional systems of medicine and genetically improve livestock and marine stock.
The policy also envisages setting up of the following specialised biotech parks in the state:
§
Pune Biotech Park for Pharmaceuticals
§
Jalna Biotech Park for Agriculture
§
Akola Biotech Park for Plant and Livestock Biotechnology
The Jalna biotech park would be conceptualised,
designed and developed by the Mahyco Research Foundation, which would help the Maharashtra
Industrial Development Corporation (MIDC) to market the park to international
biotech companies and find a strategic partner to develop infrastructure. Rabo
Bank would select a joint venture partner. MIDC would provide basic infrastructure,
develop residential areas and provide land at concessional rates for research
facilities. Agricultural biotech companies would be provided electricity at
agricultural rates.
For the Pune biotech park, Ernst & Young and Rabo Bank have been appointed to select the joint venture partner.
The draft policy envisions a Biotechnology Board with the State Chief Minister as Chairman, a Biotechnology Commission with an eminent scientist as Chairman and a Biotechnology Fund with a Rs.50 crore grant from the state government. Each state department would be required to contribute one per cent of its Plan funds to the Biotechnology Fund.
Related news:
Maharashtra to introduce biotech policy
